LETTER TO THE EDITOR
What can hide a neonatal sepsis with subsequent foot amputation?
 
More details
Hide details
 
Submission date: 2016-03-21
 
 
Acceptance date: 2016-04-07
 
 
Publication date: 2016-04-27
 
 
Arch Med Sci Civil Dis 2016;1(1):10-15
 
TOPICS
 
REFERENCES (17)
1.
Spaander MC, Hoekstra J, Hansen BE, Van Buuren HR, Leebeek FW, Janssen HL. Anticoagulant therapy in patients with non-cirrhotic portal vein thrombosis: effect of new thrombotic events and gastrointestinal bleeding. J Thromb Haemost 2013; 11: 452-9.
 
2.
Kumar A, Sharma P, Arora A. Review article: portal vein obstruction – epidemiology pathogenesis, natural history, prognosis and treatment. Aliment Pharmacol Ther 2015; 41: 276-92.
 
3.
Manzano-Robleda Mdel C, Barranco-Fragoso B, Uribe M, Méndez-Sánchez N. Portal vein thrombosis: what is new? Ann Hepatol 2015; 14: 20-7.
 
4.
Sarin SK, Sollano JD, Chawla YK, et al. Members of the APASL Working Party on Portal Hypertension. Consensus on extra-hepatic portal vein obstruction. Liver Int 2006; 26: 512-9.
 
5.
Primigiani M. Portal vein thrombosis, revisited. Digest Liver Dis 2010; 42: 163-70.
 
6.
Denninger MH, Chait Y, Casadevall N, et al. Cause of portal or hepatic venous thrombosis in adults: the role of multiple concurrent factors. Hepatology 2000; 31: 587-91.
 
7.
den Heijer M, Rosendaal FR, Blom HJ, Gerrits WB, Bos GM. Hyperhomocysteinemia and venous thrombosis: a meta-analysis. Thromb Haemost 1998; 80: 874-7.
 
8.
Sacerdoti D, Serianni G, Gaiani S, Bolognesi M, Bombonato G, Gatta A. Thrombosis of the portal venous system. J Ultrasound 2007; 10: 12-21.
 
9.
Leebeek FWG, Smalberg JH, Janssen HLA. Prothrombotic disorders in abdominal vein thrombosis. Neth J Med 2012; 70: 400-5.
 
10.
Janssen HLA, Meinardi JR, Vleggaar FP, et al. Factor V mutation, prothrombin gene mutation and deficiencies in coagulation inhibitors associated with Budd-Chiari syndrome and portal vein thrombosis: results of a case-control study. Blood 2000; 96: 2364-8.
 
11.
Demirel N, Aydin M, Zenciroglu A, et al. Neonatal thrombo-embolism: risk factors, clinical features and outcome. Ann Trop Paediatr 2009; 29: 271-9.
 
12.
Alvarez F. Risk of portal obstruction in newborns. Pediatr 2006; 148: 715-6.
 
13.
Kim JH, Lee YS, Kim SH, Lee SK, Lim MK, Kim HS. Does umbilical vein catheterization lead to portal venous thrombosis? Prospective US evaluation in 100 neonates. Radiology 2001; 219: 645-50.
 
14.
Gharehbaghi MM, Nemati M, Hosseinpour SS, Taei R, Ghargharechi R. Umbilical vascular catheter associated portal vein thrombosis detected by ultrasound. Indian J Pediatr 2011; 78: 161-4.
 
15.
Landi D, Beckman MG, Shah NR, et al. Characteristics of abdominal vein thrombosis in children and adults. Thromb Haemost 2013; 109: 625-32.
 
16.
Amitrano L, Guardascione MA, Ames PR, et al. Thrombophilic genotypes, natural anticoagulants, and plasma homocysteine in myeloproliferative disorders: relationship with splanchnic vein thrombosis and arterial disease. Am J Hematol 2003; 72: 75-81.
 
17.
Kluijtmans L, Young IS, Boreham CA, et al. Genetic and nutritional factors contributing to hyperhomocysteinemia in young adults. Blood 2003; 101: 2483-8.
 
ISSN:2451-0637
Journals System - logo
Scroll to top